Geode Capital Management’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-62,817
Closed -$796K 4016
2014
Q3
$796K Buy
62,817
+3,575
+6% +$53.4K ﹤0.01% 2925
2014
Q2
$1.01M Buy
59,242
+1,348
+2% +$20.1K ﹤0.01% 2798
2014
Q1
$779K Buy
57,894
+2,385
+4% +$31.2K ﹤0.01% 2925
2013
Q4
$709K Buy
55,509
+4,042
+8% +$42.4K ﹤0.01% 2909
2013
Q3
$465K Buy
51,467
+3,014
+6% +$25K ﹤0.01% 2989
2013
Q2
$349K Buy
+48,453
New +$356K ﹤0.01% 3028

Geode Capital Management's DRTX Position: Q4 2014 in Review

Geode Capital Management sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 62,817 shares — an estimated $796K sold.

Geode Capital Management first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $1.01M in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • Geode Capital Management reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Geode Capital Management sold 62,817 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $796K.
  • Geode Capital Management first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • Geode Capital Management's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $1.01M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Geode Capital Management's 13F filing for Q4 2014, filed 12 Feb 2015.